Articles
We are proud and honoured to announce that we have been chosen as a Syneos Health Catalyst site. This partnership will expand Syneos Health's clinical trial capabilities in New Zealand, with the collaboration focusing on various therapeutic areas such as CNS and Vaccines.
Syneos Health is a global leader and a fully integrated biopharmaceutical solutions organisation. By joining the Syneos Health Catalyst Site Program, our team at Optimal will work together with Syneos Health to improve clinical research delivery through global insights and best practices.
Together, we will drive patient-centric research, delivering outstanding research experiences and high-quality results.
We are excited to be part of this prestigious program and contribute to advancing medical solutions and patient care.
Read the full press release here or click the button below.